Flagship's latest boast? A startup that will 'revolutionize treatment' for 'ninety percent of human illness' - Endpoints News

Christopher Austin has spent the last decade building a government agency known in part for helping change drug development for rare diseases. Now, he'd like to focus on the far more common ones. On Wednesday Austin and the VC firm Flagship Pioneering announc…

Pfizer was a late arrival to the heavyweight Phase III fight to gain a first approval for an RSV vaccine, but the pharma giant has shown plenty of promise in making up lost time. And theyre kicking u… [+778 chars]

full article...